Last updated: February 13, 2026
Overview
NDC 70010-0029 corresponds to a drug marketed as generic Topiramate, primarily used for epilepsy, migraine prophylaxis, and other off-label indications. The drug is manufactured by specific pharmaceutical companies, with generic versions increasing competition and affecting pricing dynamics.
Market Landscape
- Therapeutic Area: Neurology, focusing on seizure disorders and migraine.
- Market Size (2023): The global anti-epileptic drugs market was valued at approximately $4.6 billion, with Topiramate representing a significant segment due to its widespread use.
- Key Competitors: Other anti-epileptics, including Levetiracetam, Lamotrigine, Valproic Acid, and newer agents like Lacosamide, influence market share and price elasticity.
- Regulatory and Patent Status: The original patent expired in 2004, leading to multiple generic manufacturers. Current market prices are primarily driven by generic competition.
Current Pricing
- Wholesale Acquisition Cost (WAC): The average WAC for a 100 mg tablet of generic Topiramate is approximately $0.15–$0.25.
- Per-Unit Price: For a standard 25 mg tablet, WAC ranges from $0.04–$0.07.
- Retail Price: Consumer prices vary but generally fall within $0.20–$0.50 per tablet, depending on pharmacy discounts and insurance coverage.
- Pricing Trends: Over the last five years, prices for generic Topiramate have declined by approximately 15–25% due to increased competition.
Market Projections (2024–2028)
| Year |
Estimated Market Size (USD billions) |
Expected Growth Rate |
Key Drivers |
| 2024 |
$4.2 |
-8.7% |
Patent expiries, increased generics, price competition |
| 2025 |
$3.9 |
-7.1% |
Market saturation, decline in new prescriptions |
| 2026 |
$3.7 |
-5.1% |
Competition from branded alternatives, off-label use decline |
| 2027 |
$3.4 |
-8.1% |
Consolidation, price pressures |
| 2028 |
$3.2 |
-5.9% |
Further generic entry, pricing stabilization |
Note: The decline reflects a combination of market saturation, increased generic competition, and shifting prescriptive practices.
Price Projections
- Average Wholesale Price (AWP): Expected to decrease annually by an average of 2–4%, reaching about $0.13–$0.15 per 100 mg tablet by 2028.
- Patient Out-of-Pocket: With insurance adjustments, consumer costs for a typical prescription (30-day supply of 100 mg tablets) may range from $6 to $20 monthly, depending on copay and formulary positioning.
- Market Influences: Price stabilization is anticipated as the market matures, with limited scope for significant price increases unless new formulations or indications emerge.
Key Market Factors
- Impact of Biosimilars and Generics: Entry of multiple generic manufacturers continues to drive prices downward.
- Insurance Dynamics: Formularies favor generics, controlling retail prices, but high-dose or specialized formulations could command higher prices.
- Regulatory Environment: Approvals of new formulations or combinations could influence product positioning and pricing.
Regulatory and Policy Considerations
- Price regulations differ by region; the U.S. sees limited direct regulation, but Medicaid and Medicare rebate policies influence net prices.
- Potential policy shifts to control drug prices could exert additional downward pressure.
Conclusion
The market for NDC 70010-0029 (generic Topiramate) is characterized by high competition and declining prices. The overall market size diminishes slightly through 2028, with prices reducing in tandem due to increased generic availability. Future demand remains stable for existing indications, but growth is constrained by market saturation and emerging competition.
Key Takeaways
- The market for generic Topiramate is mature, with a downward trend in both market size and price.
- Wholesale prices for tablets are expected to decrease by approximately 8–15% over the next five years.
- Market size is projected to decline gradually, reflecting competition and prescription trends.
- Price stabilization may occur if new formulations or indications are introduced.
- Policy and insurance dynamics heavily influence net prices and patient access.
FAQs
1. What factors most influence the price of NDC 70010-0029?
Increased competition among generic manufacturers, market saturation, and insurance formulary preferences are primary influences. Regulatory policies and potential introduction of new formulations also impact pricing.
2. How does generic competition affect market share?
Multiple generic manufacturers lead to price reductions and split market share, reducing revenue per unit for each manufacturer.
3. Is there potential for price increases in the foreseeable future?
Limited unless new indications, formulations, or patent protections emerge. Current trends favor price declines driven by generics.
4. How do healthcare policies impact pricing?
Programs like Medicaid and Medicare rebates influence net prices paid by payers. Policy shifts could further tighten pricing controls.
5. What is the outlook for patient costs?
Patient out-of-pocket costs are likely to decline proportionally with wholesale prices, barring new co-pay tiering or formulary restrictions.
Sources
- IQVIA, "Pharmaceutical Market Outlook," 2023.
- Medi-Span, "Drug Pricing Data," 2023.
- U.S. Food & Drug Administration, "Patent and Exclusivity Status for Topiramate," 2022.
- Centers for Medicare & Medicaid Services, "Drug Price Strategies," 2023.
- MarketWatch, "Anti-Epileptic Drugs Market Size," 2023.
